As of 2:32 PM on the 15th, Celltrion is trading at 335,000 KRW, up 0.9% from the previous day. This is a 9.7% decrease compared to February 1. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Today, foreigners are tentatively recorded as net sellers of 21,729 shares of Celltrion, and institutions are net sellers of 18,000 shares. Over the past five days, individual investors have net purchased 257,826 shares, while foreigners and institutions have net purchased 127,547 shares and net sold 391,700 shares, respectively.


On February 8, Celltrion was a market topic with the headline "Strong performance due to MFDS approval of COVID-19 antibody treatment."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing